In addition, CALML3-AS1 is also one of the low-grade glioma immune-related lncRNAs we screened, and it has been reported to inhibit microRNA-4316 in bladder cancer, thereby upregulating ZBTB2 and promoting tumorigenesis of bladder cancer [19]. Here, CALML3 is linked to urinary bladder carcinoma.